DSRU says more research needed to understand immunocompromised patients’ responses to COVID-19 vaccines
Studies showed immunosuppression appeared to weaken immune responses to COVID-19 vaccines
Read More
Tag: DSRU
New consortium will monitor safety/efficacy of COVID-19 vaccines
The move provides the opportunity to conduct essential post-marketing surveillance
Read More
Improve brand and batch number recording, urge drug safety professionals
A new study revealed that doctors and nurses only recorded batch numbers for biologic medicines between 38% and 58% of the time.
Read More
- Storm Therapeutics and AlidaBio launch collaboration to advance RNA‑targeting cancer therapies
- Excellence adventure
- MHRA approves Nucala for eosinophilic COPD in adults on triple therapy
- Bial launches new sublingual Parkinson’s treatment in UK
- Acesion Pharma launches phase 2 trial of AP31969 in atrial fibrillation
